Rapid Assessment of Polio Virus Antibodies Prevalence Amongst Children in Kano State, North West Nigeria by Yusuf, KM et al.




Polio Virus Antibodies Prevalence Amongst Children In Kano State 
RAPID ASSESSMENT OF POLIO VIRUS ANTIBODIES 
PREVALENCE AMONGST CHILDREN IN KANO STATE, NORTH 
WEST NIGERIA 
  
1Yusuf Kabir Mawashi⃰, Jatau David Edward±, Olonotola Steve±, Yakubu Edward±, Suleiman Abubakar Babangida±, Nuhu Adamu⃰, Zubairu 
Gaiyya±, Yahaya, Aminu El- Ladanⱡ 
 
⃰ Department of Disease Control and Immunization, National Primary Health Care Development Agency, Abuja, Nigeria. 
± Department of Microbiology, Ahmadu Bello University Zaria, Nigeria. 
ⱡHassan Usman Katsina State Polytechnic 
 




The completion of poliomyelitis eradication is a global health 
emergency which must be pursued with vigour. Kano state has 
remained one of the epicenters for polio virus outbreaks in 
northern Nigeria. There is paucity of information as it relates to 
polio antibody prevalence amongst children in the state. Periodic 
serologic assessment is needed to determine the quality and 
effectiveness of routine vaccination campaigns carried in the state 
to rapidly build immunity against poliovirus. Children were 
randomly selected throughout the state for the assessment 
between Sept. 2013 and Jan. 2014. Blood samples were 
collected from eighty children and tested for the presence of 
antibodies to the three poliovirus serotypes. Indirect ELISA was 
used to rapidly screen for the antibodies. Epi Info 3.5.4 version 
was used for the data analysis. Out of the samples collected, 61 
(76.3%) had antibodies to all the serotypes. While 73 (91.3%), 66 
(82.5%) and 72 (90%) had antibodies to virus serotypes 1, 2 and 
3 respectively. Age of the children, number of doses the children 
had taken and educational level of the children’s fathers were 
statistically significant risk factors on the prevalence of poliovirus 
antibodies. Access to immunization services must be improved in 
urban and rural areas so as to effectively reach a large number of 
children in those places. Effective and high quality campaigns are 
needed so that every eligible child is reached. Greater focus on 
good mobilization is also needed to reach children in households 
in rural areas as well as in households with children whose 
fathers’ educational level was low. 
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INTRODUCTION 
It is now almost three decades that the initiative to eradicate 
polioviruses by the international community was launched (WHO, 
1988). Polioviruses have been known to cause paralysis 
especially in unimmunized or sub-optimally immunized children 
(Mark, 2006; Tapani, 2006). Vaccination which enable a child to 
develop protective antibodies is the only way to prevent him/her 
from coming down with paralysis (NIAID, 2008). There are three 
poliovirus serotypes (types 1, 2 or 3) which cause poliomyelitis. 
They are spread by faecal-to-oral and oral-to-oral transmission 
(Shibuya and Murray, 2004).Children are thought to play a 
dominant role in the transmission of Polioviruses within 
populations (Fine and Ritchie, 2006), although the effect of age 
alone on the prevalence and severity of poliomyelitis is difficult to 
specify with confidence (Moore et al., 1982). Poor sanitation and 
hygiene is thought to contribute to the age profile of cases in 
developing countries (CDC, 2006).  
Reduction in poliomyelitis cases was due to extensive use of two 
vaccines, the live attenuated oral Poliovirus vaccine (OPV) or the 
Sabin vaccine (Friedrich, 2000), and the inactivated Poliovirus 
vaccine (IPV), or the Salk vaccine, (Combiescu, 2007). 
Seroconversion is poor in most African countries (Mastroeni et al., 
1997). Immuno-surveillance is not required by the World Health 
Organization, but will provide insight into the protective levels of 
populations particularly in countries with pockets of unvaccinated 
persons (Van Loon et al., 1998). High (Oderinde et al., 2012) and 
low (Marta et al., 2013) serum antibody prevalence levels against 
polioviruses had been reported. 
Many scholars had studied the effects of factor association and 
antibody prevalence in children. Some factors had been found to 
have statistically significant effect on antibody prevalence, while 
others did not (Dashe et al., 2010). Factors such as gender, water 
source, nature of place of residence, in most researches, had no 
significant relationship, except in few instances like what Mehra 
and Bansal (1990) reported. In one study it was observed that 
prevalence of polio-like paralysis was significantly higher in the 
urban population than in rural areas (Chaturvedi et al., 1978). 
Likewise immunity level had been found to be correlated with the 
number of vaccine doses taken (Allen et al., 2010).  
The cornerstone of the Global Polio Eradication Initiative (GPEI) 
is immunization of children with multiple doses of oral poliovirus 
vaccine (OPV), via both routine immunization (RI) and 
supplementary immunization activities (SIAs) (CDC, 2010). It is 
customary in any country where a comprehensive program to 
vaccinate children against Polioviruses was undertaken; from time 
to time laboratory study aimed at investigating the immune status 
of the eligible children or even the entire population to 
Polioviruses is done (Pacsa et al., 1994). 
Kano State in northern Nigeria administers to eligible children 
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trivalent vaccines) for the purpose of vaccinating children during 
campaigns and routine immunization services respectively. These 
vaccines were chosen probably because of their unique 
characteristics (Sutter et al., 2008). Routine immunization and 
campaigns are some of the strategies for polio eradication (CDC, 
2010), which enable children to react and develop antibodies to 
the introduced antigens. Only three countries (Nigeria, 
Afghanistan and Pakistan) are polio endemic as against to 125 
countries in 1988 (WHO, 2014). 
This study is aimed at serologic assessment of the immunization 
activities carried out in the state, so as to determine the quality 
and effectiveness of the routine immunization and polio 
campaigns carried.  
 
MATERIALS AND METHOD 
 
Study Area: 
Kano state is located in the north-western part of Nigeria. It is 
amongst the most populous states of Nigeria. It was created in 
May 1967 from part of the Northern region. Kano state borders 
Katsina state to the north-west, Jigawa state to the north-east, 
Bauchi state to the south-east and Kaduna state to the south-
west. The capital of Kano state is Kano. 
 
Study Design: 
A health facility based cross-sectional study design involving both 
quantitative and qualitative approaches was employed. The study 
was carried out between Sept. 2013 and Jan.2014 in Kano state, 
northern Nigeria. 
 
Study Population Including Inclusion and Exclusion Criteria: 
Children aged between 0 – 59 months were selected in three 
health facilities in each of the three senatorial districts of Kano 
state. Children outside this age group or were not resident in the 
state were excluded from the study as well as children whose 
mothers or caregivers did not give consent for their enrollment in 
the study.  
 
Sampling Techniques and Sample Size Estimation: 
Mothers with eligible child/children attending one of the three 
clinics for services were systematically stratified into rural or 
urban area settlers. Children were randomly enrolled from the 
three selected health facilities. About 80 children were enrolled 
across the state. The sample size should have been larger than 
what was obtained for the study for meaningful interpretation of 




Data Collection Form:  
Questionnaires were administered to capture all relevant 
information and bio - data of participants. 
 
Data Analysis: 
All data obtained from the study were analyzed using Epi Info 




Consents were sought and obtained from mothers or caregivers 
after explaining what the study was all about, before enrolling the 
children in the study. Ethical clearance was sought from the State 
Ethical Committee before embarking on the exercise and 
approval was granted. The study protocol conforms to 
international ethical guidelines of Helsinki declaration. 
 
Laboratory Analysis: 
About 5ml of blood sample was collected from each of the 
enrolled children into a plain labeled tube. The tubes were 
transported to laboratory in cold boxes which ice-packs were 
earlier placed so as to preserve the samples. The tubes 
containing the samples were centrifuged at 3,000 revolutions per 
minute for 5 minutes. Serum from the centrifuged sample was 
collected in another labeled tube and processed immediately or 
was stored at –20⁰C until processed. The polio ELISA test kit 
manufactured by antibodies-online GmbH was used for the 
detection of specific antibodies against specific polio virus in the 




Out of the eighty samples collected, 61 (76.3%) had antibodies to 
all the serotypes. While 73 (91.3%), 66 (82.5%) and 72 (90%) had 
antibodies to types 1, 2 and 3 polioviruses respectively.  The 
children in the 12-23 months age group had antibodies to all the 
three polio virus serotypes (Table1). The antibody prevalence 
difference was statistically significant between the age-groups.  It 
turns out to be that older children had more poliovirus antibodies 
than younger ones. Male and female children sampled exhibited 
different levels of poliovirus antibody prevalence as shown in 
table 1. The difference however between the two groups was not 
statistically significant.  
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        Table 1: Poliovirus seropositivity by age-group and sex of the children. 




X² calculated X² Tabulated P-value Decision 
Age-group 
 
0 – 11 
 
12 – 23 
 
24 – 35 
 
36 – 47 
 







































































































































Table 2 shows the number of oral polio vaccine (OPV) doses 
each child was claimed to have received and the corresponding 
poliovirus antibody prevalence.  It was apparent from the data 
that, children who had higher doses of OPV tends to show more 
antibody prevalence. The difference between the various 
groupings was found to be statistically significant (p<0.05). 
Children in the urban areas had more poliovirus antibody 
prevalence than those from rural areas (table 2), but the 
difference was not statistically significant (p >0.05).Fathers who 
had education up to tertiary level, their children had the highest 
poliovirus antibody prevalence (100%), while those children 
whose fathers’ educational level stopped at primary level had the 
lowest poliovirus antibody prevalence (table 2).  
 
         Table 2: Prevalence of poliovirus antibodies by number of doses taken, location and educational level of the father. 
Variable Sample 
tested 
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DISCUSSION 
The 73.6% of the children sampled who had antibodies to all the 3 
poliovirus serotypes appeared to be lower than what a country 
that had eradicated poliovirus reported in a similar survey (Jee et 
al., 2004). Antibodies to poliovirus types 1 and 3 appeared to be 
higher than against serotype 2, though other researchers had 
different results (Simonetta et al., 2004). What was seen in this 
study could be as a result of children being reached more through 
campaigns than through routine immunization. Campaigns 
vaccines are mainly bivalent oral polio vaccines (bOPV), while 
trivalent vaccine (tOPV) is used during routine immunization. 
Therefore the number of campaigns the state had could have had 
a significant effect on the prevalence of poliovirus antibodies. The 
vaccine type used during vaccination programme actually had an 
effect on the overall antibody type developed (Richardson et al., 
1995). 
We found out that age naturally determined the number of doses 
taken either through routine immunization or during campaigns. 
That might be the reason why older children had more antibody 
prevalence than younger ones.  Increase of immunity level with 
age had earlier been associated with age (Adewumi et al., 2006). 
We were able to find out that gender had no effect on the overall 
prevalence of poliovirus antibody, meaning to say that both male 
and female children had equal chances of being immunized 
during routine immunization sessions or through campaigns. This 
agrees well with what had been observed (Adewumi et al., 2006). 
This study was able to support previous findings (Chen et al., 
1996) that Vaccine doses taken by children affect poliovirus 
antibody prevalence in the population. However children who 
were reported to have had more doses of vaccines in some 
instances had lower poliovirus antibody prevalence. This might be 
as a result of some mothers’ inability to recall the actual vaccine 
doses taken as in most cases no card was presented to support 
what the mothers reported.    
The state over the years, had built many health facilities 
especially in urban areas which offer immunization services to 
clients. While in rural areas, attention had been given to 
increasing the number of out-reaches conducted by immunization 
personnel. We found out that, this had resulted in almost closing 
the gap in terms of poliovirus antibody prevalence between urban 
and rural areas. This may explain why the difference between the 
two locations was not statistically significant.  
We found out that education as in most other studies (Swartz et 
al., 1972) had a positive effect on the poliovirus antibody 
prevalence in the state. The higher the educational level of the 
father, the higher the prevalence of poliovirus antibody in the 
children sampled.  
Despite the overall progress recorded in the fight against 
poliomyelitis in Nigeria, a lot needs to be done particularly in Kano 
state, as the overall result has shown. 
More samples should have been taken if not for financial limitation 
which the study faced. This will provide basis for meaningful 
interpretation of results. Therefore further studies in this and 
neighbouring states are recommended involving larger samples to 
comprehensively evaluate the progress made so far, not only for 
poliomyelitis but all vaccine preventable diseases. 
 
CONCLUSION 
We can reasonably conclude that the age of the children, number 
of vaccine doses the children had taken and educational level of 
the fathers were positively associated with the prevalence of 
poliovirus antibodies. Therefore immunization authorities should 
study carefully the situation and find possible ways and methods 
to make good use of these findings, so as to ensure every eligible 
child is reached and vaccinated. Access to immunization services 
must be increased, scheduled sessions in urban and rural areas 
must be adhered to and high quality campaigns should be 
ensured so as to quickly increase immunity level in the state 
overall. Greater focus on good mobilization is needed to reach 
children in households in rural areas as well as in households with 
children whose fathers’ educational level is low.     
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